Philip D Stein

Introduction

Philip D. Stein, based in Pennington, NJ, is a prolific inventor with a remarkable portfolio of 28 patents. His work primarily focuses on pharmaceuticals, showcasing his commitment to advancing medical treatments and therapies. Through a combination of innovative thinking and rigorous scientific research, Stein has contributed significantly to the field of drug development.

Latest Patents

Among his most notable patents are the non-systemic TGR5 agonists, which encompass sulfonamide compounds designed to treat diabetic diseases in humans. The invention details pharmaceutical compositions containing these compounds, enabling the treatment of metabolic disorders through well-defined methodologies. Additionally, Stein has developed substituted 2-alkyl-1-oxo-N-phenyl-3-heteroaryl-1,2,3,4-tetrahydroisoquinoline-4-carboxamides aimed at antimalarial therapies. This innovation provides novel compounds and synthetic methods that could prevent and treat malaria, reflecting his dedication to addressing significant health challenges.

Career Highlights

Throughout his career, Philip D. Stein has collaborated with renowned companies such as Bristol-Myers Squibb Company and E.R. Squibb & Sons, Inc. His involvement in these prestigious organizations has allowed him to leverage resources and expertise, furthering his innovative endeavors in the pharmaceutical landscape.

Collaborations

Stein has also worked closely with colleagues including Steven E. Hall and Yan Shi. These collaborations have fostered an environment of creativity and problem-solving, enabling the development of groundbreaking inventions that impact public health.

Conclusion

Philip D. Stein's contributions to the medical field through his patents reflect his innovative spirit and dedication to improving health outcomes. With a solid track record of successful inventions, he continues to influence the pharmaceutical industry, paving the way for new treatments and therapies that address critical medical needs.